1-(4-chlorophenyl)-2-[(1-phenyl-1H-1,2,3,4-tetraazol-5-yl)sulfanyl]-1-ethanone | 40253-59-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-(4-chlorophenyl)-2-[(1-phenyl-1H-1,2,3,4-tetraazol-5-yl)sulfanyl]-1-ethanone
• 英文别名: 1-(4-chloro-phenyl)-2-(1-phenyl-1H-tetrazol-5-ylsulfanyl)-ethanone；1-(4-chlorophenyl)-2-[(1-phenyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]ethan-1-one；1-(4-chlorophenyl)-2-(1-phenyltetrazol-5-yl)sulfanylethanone
• CAS: 40253-59-6
• 化学式: C₁₅H₁₁ClN₄OS
• 分子量: 330.798
• InChiKey: SQQMSXILPFYEQE-UHFFFAOYSA-N

物化性质

• 沸点：
  546.9±56.0 °C(Predicted)
• 密度：
  1.41±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  86
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  1-(4-chlorophenyl)-2-[(1-phenyl-1H-1,2,3,4-tetraazol-5-yl)sulfanyl]-1-ethanone 生成 6-(4-chloro-phenyl)-3-phenyl-thiazolo[3,2-d]tetrazolium; perchlorate
  参考文献：
  名称：

  Alper,H.; Stout,R.W., Journal of Heterocyclic Chemistry, 1973, vol. 10, p. 5 - 10

  摘要：

  DOI：
• 作为产物：
  描述：

  对氯苯乙酮 在 溴 、 三乙胺 作用下， 以 乙醚 为溶剂， 反应 0.17h， 生成 1-(4-chlorophenyl)-2-[(1-phenyl-1H-1,2,3,4-tetraazol-5-yl)sulfanyl]-1-ethanone
  参考文献：
  名称：

  5-杂芳基硫烷基-4-芳基1,2,3-硒代/噻二唑的合成与表征

  摘要：

  2-甲基-5-[（4-芳基-1,2,3-硒基二氮杂-5-基）硫烷基] -1,3,4-噻二唑，5- [4-芳基-1,2-的合成及光谱表征，3-selenadiazol-5-yl] sulfanyl-1-phenyl-1 H -1,2,3,4-tetraazoles，4-aryl-5-[（5-methyl-1,3,4-thiadiazol-2- ）]，1,2,3-噻二唑和5- [4-芳基-1,2,3-噻二唑-5-基]硫烷基-1-苯基-1 H -1,2,3,4-四唑已经报道。 2-甲基-5-[（4-芳基-1,2,3-硒基二氮杂-5-基）硫烷基] -1,3,4-噻二唑，5- [4-芳基-1,2-的合成及光谱表征，3-selenadiazol-5-yl] sulfanyl-1-phenyl-1 H -1,2,3,4-tetraazoles，4-aryl-5-[（5-methyl-1,3,4-thiadiazol-2-

  DOI：

  10.1007/s12039-011-0160-x

文献信息

• Organophotoredox-Catalyzed Sulfurization of Alkenes and Alkynes: Selective and Controlled Synthesis of Sulfoxides, β-Hydroxysulfoxides, and β-Keto Sulfides
  作者：Rajjakfur Rahaman、Md Tanjul Hoque、Dilip K. Maiti

  DOI：10.1021/acs.orglett.2c02307

  日期：2022.9.30

  novel, benign, and metal-free strategy for the difunctionalization of alkenes and alkynes using organophotoredox catalyst Eosin Y. The selective and controlled synthetic approach shows good substrate generality to afford sulfoxides, β-hydroxysulfoxides, and β-keto sulfides in high yield and excellent regioselectivity.

  已经证明了使用环保空气 (O 2 ) 作为唯一氧化剂的可见光有机光氧化还原催化烯烃和炔烃与芳族和杂芳族硫醇的硫化。所建立的方法为使用有机光氧化还原催化剂 Eosin Y 对烯烃和炔烃进行双官能化提供了一种新颖、良性和无金属的策略。选择性和可控的合成方法显示出良好的底物通用性，可提供亚砜、β-羟基亚砜和 β-酮硫化物产率高，区域选择性好。
• Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies
  作者：Selvam Chitra、Nidhin Paul、Shanmugam Muthusubramanian、Paramasivam Manisankar、Perumal Yogeeswari、Dharmarajan Sriram

  DOI：10.1016/j.ejmech.2011.07.046

  日期：2011.10

  A series of 3-heteroarylthioquinoline derivatives has been synthesized by the Friedlander annulation of 2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]-1-aryl-1-ethanone/2-(1,3-benzothiazol-2-ylsulfanyl)-1-aryl-1-ethanone/1-aryl-2-[(2-phenyl-2H-1,2,3,4-tetraazol-5-yl)sulfanyl]-1-ethanone with 2-aminobenzophenone in good yields using YbCl3 as the catalyst. These compounds have been screened for their in vitro activity against Mycobacterium tuberculosis H37Rv (MTB) and among the 21 compounds screened, 2-[2-(4-bromophenyl)-4-phenyl-3-quinolyl]sulfanyl-5-methyl-1,3,4-thiadiazole (5d) and 2-[2-(4-chlorophenyl)-4-phenyl-3-quinolyl]sulfanyl-5-methyl-1,3,4-thiadiazole (5c) were found to be the most active compounds with MIC of 3.2 and 3.5 mu M respectively against MTB. The cytotoxic effects against mouse fibroblasts (NIH 3T3) in vitro were evaluated for 5c and 5d, which displayed no toxic effects (IC50 > 1000 mu M) against the mouse fibroblast cell line NIH 3T3. (C) 2011 Elsevier Masson SAS. All rights reserved.
• [EN] 1,5-SUBSTITUTED TETRAZOLES AS THERAPEUTIC COMPOUNDS<br/>[FR] TETRAZOLES 1,5-SUBSTITUÉS EN TANT QUE COMPOSÉS THÉRAPEUTIQUES
  申请人：UNIV EDINBURGH

  公开号：WO2007029021A1

  公开（公告）日：2007-03-15

  [EN] The present invention pertains to certain 1,5-substituted-1H-tetrazole compounds that, inter alia, inhibit 11ß- hydroxysteroid dehydrogenase type 1 (11ß-HSD1). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, bothin vitro and in vivo, to inhibit 11ß-hydroxysteroid dehydrogenase type 1; to treat conditions that are ameliorated by the inhibition of 11ß-hydroxysteroid dehydrogenase type 1; to treat the metabolic syndrome, which includes conditions such as type 2 diabetes and obesity, and associated disorders including insulin resistance, hypertension, lipid disorders and cardiovascular disorders such as ischaemic (coronary) heart disease; to treat CNS conditions such as mild cognitive impairment and early dementia, including Alzheimer's disease; etc.
  [FR] La présente invention concerne certains composés 1H-tétrazole 1,5 substitués qui, notamment, inhibent la 11ß-hydroxystéroïde déshydrogénase de type 1(11ß-HSD1). Cette invention concerne également des compositions pharmaceutiques comprenant ces composés et l'utilisation de ces composés et compositions, tant in vitro qu'in vivo, afin d'inhiber la 11ß-hydroxystéroïde déshydrogénase de type 1; afin de traiter des pathologies atténuées par l'inhibition de la 11ß-hydroxystéroïde déshydrogénase de type 1; afin de traiter le syndrome métabolique, qui inclut des affections telles que le diabète de type 2 et l'obésité, ainsi que des pathologies associées, notamment l'insulinorésistance, l'hypertension, les troubles lipidiques et les pathologies cardiovasculaires telles que les maladies cardiaques ischémiques (coronariennes) ; afin de traiter des affections du SNC telles que le déficit cognitif léger et la démence précoce, y compris la maladie d'Alzheimer; etc.
• Synthesis and characterization of 5-heteroarylsulfanyl-4-aryl- 1,2,3-selena/thiadiazoles
  作者：RAMAIYAN MANIKANNAN、MASILAMANI SHANMUGARAJA、SEETHARAMAN MANOJVEER、SHANMUGAM MUTHUSUBRAMANIAN

  DOI：10.1007/s12039-011-0160-x

  日期：2012.3

  Synthesis and spectral characterization of 2-methyl-5-[(4-aryl-1,2,3-selenadiazol-5-yl)sulfanyl]-1,3,4-thiadiazoles, 5-[4-aryl-1,2,3-selenadiazol-5-yl]sulfanyl-1-phenyl-1H-1,2,3,4-tetraazoles, 4-aryl-5-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]-1,2,3-thiadiazole and 5-[4-aryl-1,2,3-thiadiazol-5-yl]sulfanyl-1-phenyl-1H-1,2,3,4-tetraazole have been reported. Synthesis and spectral characterization of

  2-甲基-5-[（4-芳基-1,2,3-硒基二氮杂-5-基）硫烷基] -1,3,4-噻二唑，5- [4-芳基-1,2-的合成及光谱表征，3-selenadiazol-5-yl] sulfanyl-1-phenyl-1 H -1,2,3,4-tetraazoles，4-aryl-5-[（5-methyl-1,3,4-thiadiazol-2- ）]，1,2,3-噻二唑和5- [4-芳基-1,2,3-噻二唑-5-基]硫烷基-1-苯基-1 H -1,2,3,4-四唑已经报道。 2-甲基-5-[（4-芳基-1,2,3-硒基二氮杂-5-基）硫烷基] -1,3,4-噻二唑，5- [4-芳基-1,2-的合成及光谱表征，3-selenadiazol-5-yl] sulfanyl-1-phenyl-1 H -1,2,3,4-tetraazoles，4-aryl-5-[（5-methyl-1,3,4-thiadiazol-2-
• Alper,H.; Stout,R.W., Journal of Heterocyclic Chemistry, 1973, vol. 10, p. 5 - 10
  作者：Alper,H.、Stout,R.W.

  DOI：——

  日期：——